Eli Lilly

weight loss scale weigh measure tape obesity overweight

Biotech

Lilly's amylin data impress with 11% weight loss, tolerability

Eli Lilly impressed analysts with results that point to the potential for the drug candidate to form part of a market-leading Zepbound combination.

Nick Paul Taylor Jun 16, 2025 4:55am

Ozempic syringe pen and measuring tape on blue background

Novo plots ph. 3 trials for next-gen obesity asset amycretin

Jun 13, 2025 10:35am

Anatomical model of human arm and torso showing muscle

Eli Lilly inks $650M Juvena pact to find muscle-boosting drugs

Jun 11, 2025 7:30am

Antares and Rho Ophiuchi cloud complex in the Sagittarius constellation

Scorpion spinout Antares raises $177M for preclinical portfolio

Jun 10, 2025 10:07am

photo of a pair of binoculars perched on a rock aimed at the rising sun

Are Lilly, Novartis eyeing the PD-1xVEGF field? Execs weigh in

Jun 4, 2025 1:00pm

Graphic images of white and black puzzle pieces connecting seamlessly

Eli Lilly taps Camurus' tech to advance long-acting obesity meds

Jun 3, 2025 5:04pm